TAVI PCI
2026
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention — The TAVI PCI Trial
In 986 patients with severe aortic stenosis and coronary disease, PCI after TAVI was non-inferior to PCI before TAVI for death, myocardial infarction, revascularisation, rehospitalisation or major bleeding at 1 year.
Risultato
- Differenza assoluta
- 2,0 punti
risk difference-2,0IC 95% -7,4 to 3,4 · P < 0,001
La differenza assoluta è derivata dai tassi di eventi.
Riportato inoltre: BARC 3a or worse bleeding 6.6% vs 9.7%.
- Sottotema
- TAVR and PCI
- Disegno
- prospective, international, multicentre (Austria, France, Germany, Italy, Netherlands, Switzerland), open-label, 2-arm RCT; 1:1 PCI after TAVI vs PCI before TAVI (each within 1–45 days); non-inferiority; primary endpoint at 1 year, follow-up to 5 years
- Rilevanza
- Importante: uno dei diversi pilastri.
- Fonte
- Stähli BE, et al. N Engl J Med. 2026; published online 30 August.doi 10.1056/nejmoa2606924
Discussione e critica
Sequence, not indication: everyone got both procedures, and the question was only which comes first. Doing the valve first is not worse, and it bleeds less: 6.6% vs 9.7%, which is the practical argument, since PCI first means antiplatelet therapy running through the valve procedure. Non-inferiority with a margin wide enough to admit a 3.4-point excess, in a mean age of 82, so this licenses a preference rather than settling a mechanism.